Survey and Research Archives | Page 5 of 98 | Be Korea-savvy

Archive by category Survey and Research

Examined: Artificial Intelligence Redefining Marketing in 2024 – From Generic Ads to Tailor-made Experiences

Examined: Artificial Intelligence Redefining Marketing in 2024 – From Generic Ads to Tailor-made Experiences

WATERFORD, Ireland, Oct. 24, 2024 (Korea Bizwire) – Marketing in 2024 is being redefined by artificial intelligence (AI) and machine learning (ML). It has already turned traditional marketing on its head, making generic adverts a thing of the past. Now, it’s all about data-driven precision and delivering tailor-made experiences that resonate with audiences. For the [...]

Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024

Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024

SAN FRANCISCO and SINGAPORE, Oct. 23, 2024 (Korea Bizwire) – Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced a poster presentation on HMBD-802, a novel first-in-class dual-payload anti-HER2 antibody-drug conjugate, at the 36th EORTC-NCI-AACR symposium (23-25 October 2024). “We are excited to present at EORTC-NCI-AACR with data demonstrating [...]

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin’s innate glucosyltransferase in order to inhibit the toxin produced by C. diff. in the gastrointestinal tract. There are up to 175,000 cases of recurrent C. diff. each [...]

UPDATE – Politecnico di Torino as a Driving Force in Space Research

UPDATE – Politecnico di Torino as a Driving Force in Space Research

The University stars at the International Astronautical Congress 2024 in Milan Politecnico di Torino proves its prominent role in the aerospace and aeronautics research landscape with a solid presence at the IAC conference, Oct. 14-18 A stage of IAC’s Astronauts Chapter will be hosted on Tuesday, Oct. 15, at 3 p.m. in Politecnico’s Aula Magna, [...]

Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions

Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions

Quantexa earned a top ranking in the RiskTech100® 2025 Report, highlighting its strength and innovation in the expanding risk technology and compliance market LONDON, Oct. 22, 2024 (Korea Bizwire) – Quantexa, a leading provider of Decision Intelligence solutions for public and private sectors, today announced it has received recognition in two Chartis Research reports. Quantexa [...]

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer (NSCLC), and other mesothelin (MSLN) expressing cancers VANCOUVER, British Columbia, Oct. 21, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to [...]

AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024

AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024

Research Triangle Park, N.C., Oct. 17, 2024 (Korea Bizwire) – Two oral presentations and nine poster presentations will highlight exciting progress in AskBio’s clinical and pre-clinical pipeline and advancements in the company’s manufacturing technologies Alongside recent clinical program milestones, presentations demonstrate AskBio’s commitment to advancing end-to-end capabilities and goal of delivering breakthrough therapies Asklepios BioPharmaceutical, [...]

US utilities to face significant challenge as power demand surges for the first time in decades

US utilities to face significant challenge as power demand surges for the first time in decades

Some regions in US to see 15% electricity demand growth through 2029; prices could escalate LONDON and HOUSTON and SINGAPORE, Oct. 17, 2024 (Korea Bizwire) – US power demand has remained essentially flat for the past decade, but this is all about to change as a pending surge in demand growth will be the biggest [...]

A “Meeting of the Minds” on Hybrid Work: Unispace’s Annual Global Survey of 10,000+ Employers and Employees

A “Meeting of the Minds” on Hybrid Work: Unispace’s Annual Global Survey of 10,000+ Employers and Employees

Working habits have evolved, yet the office itself hasn’t kept up: Employees now seek workplaces that foster individual focus, rather than reserve concentration working from home NEW YORK, Oct. 17, 2024 (Korea Bizwire) – After years of discord around hybrid schedules, the latest global survey from leading design-build firm Unispace shows that employees and employers have finally [...]